Phasefolio

Connects agents to PhaseFolio, a biotech valuation workspace for risk-adjusted NPV, probability-of-success benchmarks, scenario analysis, and Monte Carlo simulation. Reach for it when an agent needs to reason about drug pipeline economics, compare assumptions, or produce diligence artifacts without rebuilding spreadsheet models by hand. The useful angle is provenance: PhaseFolio emphasizes signed exports, evidence registers, methodology versions, backtests, and a verify endpoint, so downstream agents can check that a valuation or dossier is tied to a specific engine, dataset, and methodology before using it in an investment workflow.